TrialMed (New York, N.Y.)2020

Efficacy and Safety of Lopinavir/Ritonavir or Arbidol in Adult Patients with Mild/Moderate COVID-19: An Exploratory Randomized Controlled Trial.

Yueping Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.